Close mobile menu×
Close mobile menu

Donald W. Landry, MD

Board Certifications: 
Internal Medicine, Nephrology
Not Accepting New Patients
Profile Hero

Appointments

myColumbiaDoctors

For existing patients, login to make an appointment, view documentation or contact your care provider.

Credentials & Experience

Board Certifications

  • Internal Medicine
  • Nephrology

Education & Training

  • Columbia University College of Physicians and Surgeons
  • Residency: University of Massachusetts Medical Center
  • Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center

About Donald Landry

Academic Titles

  • Samuel Bard Professor of Medicine

Administrative Positions

  • Chair, Department of Medicine
  • Physician-in-Chief, NewYork-Presbyterian/Columbia University Medical Center

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Gender

  • Male

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Indemnity
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Access (Exchange)
  • Essential Plan
  • Medicaid Managed Care
  • Medicare Managed Care

Amida Care

  • Special Needs Plan

Emblem/GHI

  • HMO
  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Priority
  • EPO
  • HMO
  • Medicare (Mediblue)
  • NYP Employee Plan
  • Pathway (Exchange)
  • POS
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Medicare

  • Traditional Medicare (NY)

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

POMCO

  • POMCO

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • EPO
  • Essential Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • SelectHealth

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Research

Research Interests

  • Medical application of artificial enzymes
  • Pathogenesis of vasodilatory shock

Grants

CLINICAL AND TRANSLATIONAL SCIENCE AWARD (Federal Gov)

Jul 1 2016 - May 31 2021

CU-CSPC COLLABORATION FOR DRUG DISCOVERY AND DEVELOPMENT (Private)

Sep 15 2014 - Sep 14 2019

PHARMACOLOGICAL TREATMENTS FOR STARGARDT DISEASE (Private)

Jul 1 2015 - Jun 30 2018

INHIBITORS OF PURINE IMPORT INTO PLASMODIUM FALCIPARUM KILL MALARIA PARASITES (Federal Gov)

Feb 1 2015 - Jan 31 2017

ASSESSMENT OF ACTIVITY OF THE HAT AGONIST YF2 (Private)

Oct 30 2015 - Oct 29 2016

SYNTHESIS OF HAT ACTIVATORS (Private)

Oct 30 2015 - Oct 29 2016

DEVELOPMENT OF AMODIAQUINE AND ITS ANALOGS AS REACTIVATORS OF ORGANOPHOSPHATE-INH (Federal Gov)

Sep 30 2012 - Jul 31 2015

HIGH-THROUGHPUT SCREENING AND CHEMISTRY SHARED FACILITY (NY State Gov)

Aug 1 2011 - Jul 31 2015

DORIS DUKE CLINICAL RESEARCH FELLOWSHIP PROGRAM (Private)

Jan 1 2011 - Jun 30 2014

HIGHER-ACTIVITY MUTANTS OF COCAINE ESTERASE (Federal Gov)

Aug 15 2008 - Jun 30 2014

ALLOSTERIC EFFECTORS OF CHOLINESTERASE AS PRE-TREATMENTS FOR NERVE AGENCY EXPOSURE (Federal Gov)

Mar 31 2011 - Mar 31 2014

NOVEL PDE5 INHIBITORS AS A THERAPEUTIC TOOL AGAINST ALZHEIMER S DISEASE (Federal Gov)

Mar 1 2011 - Feb 28 2014

CHROMOCELL CORP (Private)

Feb 26 2008 - Feb 26 2014

HISTONE ACETYLTRANSFERASE (HAT) ACTIVATORS AS CHROMATIN REMODELERS FOR THE TREATMENT OF MEMORY LOSS IN ALZHEIMER S DISEASE (Private)

Dec 31 2010 - Dec 30 2013

RAGE SIGNAL TRANSDUCTION: NOVEL TREATMENTS FOR T1D (Private)

Mar 1 2011 - Feb 28 2013

NMR SPECTROMETER IN SUPPORT OF DRUG DISCOVERY EFFORT (Federal Gov)

Aug 1 2011 - Jan 31 2013

METABOLISM IN HEART FAILURE TRANSLATIONAL RESEARCH CENTER (Federal Gov)

Sep 30 2009 - Aug 31 2012

CORE CHEMISTRY (Private)

Jun 19 2009 - Aug 19 2012

DORIS DUKE CLINICAL RESEARCH FELLOWSHIP PROGRAM (Private)

Jan 1 2008 - Jun 30 2012

CAREER TRACKS TOWARDS EXCELLENCE (Private)

Jul 1 1993 - Jun 30 2012

TOXICITY INDICATION (COCE) (Private)

Jul 28 2008 - Jul 27 2010

MEDICAL, CHEMICAL AND BIOLOGICAL DEFENSE RESEARCH (Federal Gov)

Dec 19 2006 - Jun 18 2010

DEVELOPMENT OF ESTERASES FOR THE TREATMENT OF COCAINE OVERDO SE AND ABUSE (Federal Gov)

May 10 2006 - Apr 30 2010

ADMINISTRATION FOR 2ND YEAR FOR DORIS DUKE CLINICAL RESEARCH FELLOWS (Private)

Dec 31 2003 - Jun 30 2008

Selected Publications

  • Deng S, Bharat N, Prada P, Landry D. (2004) Substrate-assisted antibody catalysis. Org. Biomol. Chem. 2:288-90
  • Wehrens XHT, Lehnart SE, Reiken SR, Deng S-X, Vest JA, Cervantes D, Coromilas J, Landry DW, Marks AR. (2004) Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2. Science 304:292-6
  • Malay M-B, Ashton JL, Dahl K, Savage EB, Burchell SA, Ashton RC, Sciacca RR, Oliver JA, Landry DW. (2004) Heterogeneity of the vasoconstrictor effect of vasopressin in septic shock. Crit. Care Med. 32:1327-31
  • Larsen NA, de Prada P, Deng S-X, Mittal A, Braskett M, Zhu X, Wilson IA, Landry DW. (2004) Crystallographic and biochemical analysis of cocaine degrading antibody 15A10. Biochemistry 43:8067-76
  • Lehnart SE, Wehrens XH, Laitinen PJ, Reiken SR, Deng SX, Cheng Z, Landry DW, Kontula K, Swan H, Marks AR. (2004) Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak. Circulation 109:3208-14
  • Landry DW, Zucker H. (2004) Embryonic death and the creation of human embryonic stem cells. J. Clin. Invest. 114:1184-6